Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuroprotective Effect of Omega (Nano PSO), Changes in Neurotrophic BDNF and VEGF, and Their Association With Cognitive Status in Patients Who Used to Consume Psychoactive Substances

NCT06550167 is registered in ClinicalTrials.gov with Distribuidora Biolife SA de CV as lead sponsor.

NCT NCT06550167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06550167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuroprotective Effect of Omega (Nano PSO), Changes in Neurotrophic BDNF and VEGF, and Their Association With Cognitive Status in Patients Who Used to Consume Psychoactive Substances
Lead sponsor
Distribuidora Biolife SA de CV
Phase
Not applicable
Overall status
Recruiting
Start date
March 15, 2024
Completion date
March 15, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

addiction;drug(s);lsd, neuroprotective